Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
Recruiting · NCT06282588 · Registry updated 2026-03-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 / Phase 3 | 2026-03-19 | NCT06282588 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bayer | 178 |
| Cancer Research Antwerp | 6 |
| Veracyte, Inc. | 8 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| AZ Delta | Roeselare | Belgium | 43 |
| AZ Groeninge | Kortrijk | Belgium | 53 |
| AZ Sint-Jan | Bruges | Belgium | 24 |
| Azorg | Aalst | Belgium | 16 |
| CHU Liège | Liège | Belgium | 7 |
| Saint Luc | Brussels | Belgium | 2 |
| UZ Gent | Ghent | Belgium | 113 |
| Vitaz | Sint-Niklaas | Belgium | 27 |
| ZAS Sint-Augustinus | Wilrijk | Belgium | 1 |